Harmony Biosciences News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

06.06.22	HARMONY BIOSCIENCES PRESENTS POST-HOC ANALYSIS OF WAKIX® (PITOLISANT) PIVOTAL DATA IN ADULTS WITH HIGH BURDEN OF NARCOLEPSY SYMPTOMS (PR Newswire)
27.04.22	HARMONY BIOSCIENCES INITIATES PHASE 3 TRIAL OF PITOLISANT IN ADULT PATIENTS WITH IDIOPATHIC HYPERSOMNIA (PR Newswire)
19.04.22	HARMONY BIOSCIENCES ANNOUNCES DATE OF FIRST QUARTER 2022 FINANCIAL RESULTS (PR Newswire)
07.04.22	HARMONY BIOSCIENCES OPENS APPLICATIONS FOR 2022 PROGRESS AT THE HEART PROGRAM (PR Newswire)
04.04.22	HARMONY BIOSCIENCES TO PARTICIPATE IN 21st ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE (PR Newswire)
31.03.22	HARMONY BIOSCIENCES CERTIFIED AS A GREAT PLACE TO WORK® FOR FOURTH CONSECUTIVE YEAR (PR Newswire)
17.03.22	HARMONY BIOSCIENCES ANNOUNCES APPLICATIONS OPEN MARCH 18 FOR 2022 PATIENTS AT THE HEART PROGRAM (PR Newswire)
09.03.22	HARMONY BIOSCIENCES TO PARTICIPATE IN TWO INVESTOR CONFERENCES IN MARCH (PR Newswire)
14.02.22	Harmony Biosciences Announces Date of Fourth Quarter and Full Year 2021 Financial Results (PR Newswire)
05.01.22	Harmony Biosciences to Participate in 40th Annual J.P. Morgan Healthcare Conference (PR Newswire)
17.12.21	Harmony Biosciences to be Added to the Nasdaq Biotech Index (PR Newswire)
13.12.21	Harmony Biosciences Publishes Pitolisant Efficacy Data In CNS Drugs (PR Newswire)
01.12.21	Harmony Biosciences Announces Plans To Initiate Phase 3 Clinical Trial For Treatment Of Idiopathic Hypersomnia (PR Newswire)
22.11.21	Harmony Biosciences Appoints Linda Szyper To Its Board Of Directors (PR Newswire)
11.11.21	Harmony Biosciences To Participate In Two Investor Conferences In November (PR Newswire)
26.10.21	Harmony Biosciences Announces Date of Third Quarter 2021 Financial Results (PR Newswire)
21.10.21	Harmony Biosciences to be Added to the S&P SmallCap 600® Index (PR Newswire)
19.10.21	Kite Realty Group Trust Set to Join S&P MidCap 400; Harmony Biosciences Holdings & LendingTree to Join S&P SmallCap 600 (PR Newswire)
18.10.21	Harmony Biosciences - Beyond Wakix And Narcolepsy (RTTNews)
22.09.21	Harmony Biosciences Announces Winners of Patients at the Heart and Progress at the Heart on Third Annual World Narcolepsy Day (PR Newswire)
02.09.21	Harmony Biosciences To Participate In Three Investor Conferences In September (PR Newswire)
10.08.21	Blackstone Enters Into Financing Deal With Harmony (RTTNews)
10.08.21	Harmony Biosciences And Blackstone Enter Into Strategic Financing Collaboration (PR Newswire)
09.08.21	Harmony Biosciences Acquires Asset With Novel Mechanism Of Action For The Potential Treatment Of Narcolepsy And Other Rare Neurological Diseases (PR Newswire)
29.07.21	John C. Jacobs, President And CEO Of Harmony Biosciences, Named An Ernst & Young (EY) Entrepreneur Of The Year 2021 Greater Philadelphia Award Winner (PR Newswire)
27.07.21	Harmony Biosciences Announces Date Of Second Quarter 2021 Financial Results (PR Newswire)
29.06.21	Harmony Biosciences Initiates A Phase 2 Clinical Trial In Myotonic Dystrophy (PR Newswire)
10.06.21	/C O R R E C T I O N -- Harmony Biosciences/ (PR Newswire)
09.06.21	Harmony Biosciences Announces Applications for 2021 Patients At The Heart Grant Program Open June 9 (PR Newswire)
19.08.20	Harmony Biosciences Prices Upsized IPO At $24/Shr, Above The Estimated Range (RTTNews)
18.08.20	This Week's Healthcare IPOs (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

UBS Group	31.13	2.91 %	K V
Geberit	505.80	2.47 %	K V
ABB	50.70	2.09 %	K V
Holcim	87.22	2.06 %	K V
CieFinRichemont	163.75	1.21 %	K V
Swisscom	512.50	0.10 %	K V
Sonova Hldg	302.60	-0.40 %	K V
Logitech Intl	79.70	-0.62 %	K V
Roche Hldg G	265.40	-1.19 %	K V
Novartis	89.32	-1.40 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Harmony Biosciences

Aktien Top/Flop

Meistgelesene Nachrichten